These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6377568)

  • 41. Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapy.
    Watz R; Savidge GF
    Acta Med Scand; 1979; 205(4):293-8. PubMed ID: 433668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of thrombotic occlusion of the pelvic and extremity veins. Comparison of three different types of treatment].
    Kalkowski H; Rinke W; Dohse D; Herzog S
    Zentralbl Chir; 1984; 109(2):97-103. PubMed ID: 6711168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.
    Kakkar VV; Flanc C; Howe CT; O'Shea M; Flute PT
    Br Med J; 1969 Mar; 1(5647):806-10. PubMed ID: 4886628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Healing of deep venous thrombosis: venographic findings in a randomized study comparing streptokinase and heparin.
    Rösch J; Dotter CT; Seaman AJ; Porter JM; Common HH
    AJR Am J Roentgenol; 1976 Oct; 127(4):553-8. PubMed ID: 970521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coronary thrombolysis: mortality trials.
    Cairns JA
    Can J Cardiol; 1993; 9(6):490-7. PubMed ID: 8221341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
    Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
    Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg?
    Holmström M; Bratt G; Törnebohm E; Rhedin AS; Lockner D
    J Intern Med; 1990 Dec; 228(6):647-9. PubMed ID: 2280243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypotension in acute myocardial infarction patients given streptokinase.
    Lateef F; Anantharaman V
    Singapore Med J; 2000 Apr; 41(4):172-6. PubMed ID: 11063182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of deep vein thrombosis with streptokinase.
    Duckert F; Müller G; Nyman D; Benz A; Prisender S; Madar G; Da Silva MA; Widmer LK; Schmitt HE
    Br Med J; 1975 Mar; 1(5956):479-81. PubMed ID: 123806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sequelae of deep venous thrombosis, 5-year follow-up of 341 patients].
    Widmer MT; Zemp E; Voëlin R; Brandenberg E; Da Silva A
    Phlebologie; 1987; 40(4):915-21. PubMed ID: 3447194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis.
    Goldhaber SZ; Buring JE; Lipnick RJ; Hennekens CH
    Am J Med; 1984 Mar; 76(3):393-7. PubMed ID: 6367454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Actual state of thrombolytic treatment of recent vein thrombosis and pulmonary embolism (author's transl)].
    Verstraete M
    J Mal Vasc; 1981; 6(4):251-6. PubMed ID: 7198677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Deep venous thrombosis: streptokinase treatment with adaptation of the maintenance dosage].
    Theiss W; Hofer E; Kriessmann A; Lutilsky L; Sauer E; Wirtzfeld A
    Med Klin; 1980 Aug; 75(16):580-6. PubMed ID: 7412703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.
    Visconte C; Sainte-Marie M; Lorrain J; Millet L; O'Connor SE; Schaeffer P; Herbert JM
    J Thromb Haemost; 2004 Apr; 2(4):629-36. PubMed ID: 15102019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deep vein thrombosis of inferior limbs: are thrombolytic agents superior to heparin?
    Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):178-80. PubMed ID: 3306928
    [No Abstract]   [Full Text] [Related]  

  • 57. Is streptokinase useful in the treatment of deep vein thrombosis?
    Bieger R; Boekhout-Mussert RJ; Hohmann F; Loeliger EA
    Acta Med Scand; 1976; 199(1-2):81-8. PubMed ID: 1251775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic use of thrombolytic agents.
    Stambaugh RL; Alexander MR
    Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Medical treatment of ilio-caval venous thrombosis].
    Serradimigni A; Mathieu P; Sainsous J; Chiche G; Egré A
    Arch Mal Coeur Vaiss; 1981 Mar; 74(3):347-56. PubMed ID: 6782995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group.
    Alhenc-Gelas M; Jestin-Le Guernic C; Vitoux JF; Kher A; Aiach M; Fiessinger JN
    Thromb Haemost; 1994 Jun; 71(6):698-702. PubMed ID: 7974334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.